loadpatents
Patent applications and USPTO patent grants for Binch; Hayley Marie.The latest application filed is for "modulators of cystic fibrosis transmembrane conductance regulator".
Patent | Date |
---|---|
Modulators of cystic fibrosis transmembrane conductance regulator Grant 11,426,407 - Miller , et al. August 30, 2 | 2022-08-30 |
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20210052584 - Miller; Mark Thomas ;   et al. | 2021-02-25 |
Modulators of cystic fibrosis transmembrane conductance regulator Grant 10,758,534 - Miller , et al. Sep | 2020-09-01 |
Modulators of cystic fibrosis transmembrane conductance regulator Grant 10,258,624 - Miller , et al. | 2019-04-16 |
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20180185364 - Miller; Mark Thomas ;   et al. | 2018-07-05 |
Modulators of cystic fibrosis transmembrane conductance regulator Grant 9,782,408 - Miller , et al. October 10, 2 | 2017-10-10 |
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20170196862 - Miller; Mark Thomas ;   et al. | 2017-07-13 |
Compounds useful as inhibitors of ATR kinase Grant 9,630,956 - Charrier , et al. April 25, 2 | 2017-04-25 |
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator App 20160095858 - Miller; Mark Thomas ;   et al. | 2016-04-07 |
Pharmaceutical Compositions and Administrations Thereof App 20160022665 - Van Goor; Fredrick F. ;   et al. | 2016-01-28 |
Pharmaceutical Compositions and Administrations Thereof App 20160022664 - Van Goor; Fredrick F. ;   et al. | 2016-01-28 |
Morpholine-spirocyclic piperidine amides as modulators of ion channels Grant 9,181,273 - Hadida-Ruah , et al. November 10, 2 | 2015-11-10 |
Pharmaceutical Compositions and Administrations Thereof App 20150164881 - Van Goor; Fredrick F. ;   et al. | 2015-06-18 |
Pharmaceutical Compositions And Administrations Thereof App 20150164883 - Van Goor; Fredrick F. ;   et al. | 2015-06-18 |
Morpholine-spirocyclic Piperidine Amides As Modulators Of Ion Channels App 20150025073 - Hadida-Ruah; Sara Sabina ;   et al. | 2015-01-22 |
Morpholine-spirocyclic piperidine amides as modulators of ion channels Grant 8,828,996 - Hadida-Ruah , et al. September 9, 2 | 2014-09-09 |
Triazole compounds useful as protein kinase inhibitors Grant 8,633,210 - Charrier , et al. January 21, 2 | 2014-01-21 |
Pharmaceutical Compositions And Administrations Thereof App 20130158071 - Van Goor; Fredrick F. ;   et al. | 2013-06-20 |
Pharmaceutical Compositions And Administrations Thereof App 20130131107 - Van Goor; Fredrick F. ;   et al. | 2013-05-23 |
Compounds useful as inhibitors of ATR kinase Grant 8,410,112 - Charrier , et al. April 2, 2 | 2013-04-02 |
Morpholine-spirocyclic Piperidine Amides As Modulators Of Ion Channels App 20120264749 - Hadida-Ruah; Sara Sabina ;   et al. | 2012-10-18 |
Caspase inhibitors and uses thereof Grant 8,288,537 - Golec , et al. October 16, 2 | 2012-10-16 |
Compounds Useful As Inhibitors Of Atr Kinase App 20120027874 - Charrier; Jean-Damien ;   et al. | 2012-02-02 |
Caspase inhibitors and uses thereof Grant 8,093,392 - Golec , et al. January 10, 2 | 2012-01-10 |
Drug Discovery Methods App 20110269732 - GOLEC; Julian M.C. ;   et al. | 2011-11-03 |
Caspase inhibitors and uses thereof Grant 7,906,650 - Golec , et al. March 15, 2 | 2011-03-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.